PROSPECTS FOR OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN  THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS

Pulatova Sh.B., Abduazizova N.

dc.contributor.author	Pulatova Sh.B., Abduazizova N.
dc.date.accessioned	2024-03-25T11:07:31Z
dc.date.available	2024-03-25T11:07:31Z
dc.date.issued	2023-08
dc.identifier.issn	2231-2218
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10834
dc.description.abstract	A review of recommendations for the use of tumor necrosis factor α (TNF-α) inhibitors in patients with ankylosing spondylitis (AS) is presented. The data on the efficacy of TNF-α in patients with AS are presented. On the basis of international and domestic recommendations, ndications for the appointment of this therapy, criteria for assessing its effectiveness and safety are formulated.	en_US
dc.language.iso	en	en_US
dc.publisher	Asian journal of Pharmaceutical and biological research 2231-2218	en_US
dc.relation.ispartofseries	Volume 12 Issue 2;
dc.subject	ankylosing spondylitis; tumor necrosis factor-α inhibitors; efficiency; safety	en_US
dc.title	PROSPECTS FOR OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS	en_US
dc.type	Article	en_US